209 related articles for article (PubMed ID: 17692575)
1. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
2. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
3. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
4. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
Fischer S; Uetz-von Allmen E; Waeckerle-Men Y; Groettrup M; Merkle HP; Gander B
Biomaterials; 2007 Feb; 28(6):994-1004. PubMed ID: 17118442
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
6. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.
Fischer S; Foerg C; Ellenberger S; Merkle HP; Gander B
J Control Release; 2006 Mar; 111(1-2):135-44. PubMed ID: 16377017
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
8. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
[TBL] [Abstract][Full Text] [Related]
9. DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method.
Oster CG; Wittmar M; Bakowsky U; Kissel T
J Control Release; 2006 Apr; 111(3):371-81. PubMed ID: 16499988
[TBL] [Abstract][Full Text] [Related]
10. Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides.
Zhu SG; Xiang JJ; Li XL; Shen SR; Lu HB; Zhou J; Xiong W; Zhang BC; Nie XM; Zhou M; Tang K; Li GY
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):179-87. PubMed ID: 15032738
[TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
Mainardes RM; Evangelista RC
Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
13. Transport of polymeric nanoparticle gene carriers in gastric mucus.
Dawson M; Krauland E; Wirtz D; Hanes J
Biotechnol Prog; 2004; 20(3):851-7. PubMed ID: 15176891
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery.
Yi F; Wu H; Jia GL
J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119
[TBL] [Abstract][Full Text] [Related]
15. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ
Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530
[TBL] [Abstract][Full Text] [Related]
16. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
17. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
18. Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
Mansouri S; Cuie Y; Winnik F; Shi Q; Lavigne P; Benderdour M; Beaumont E; Fernandes JC
Biomaterials; 2006 Mar; 27(9):2060-5. PubMed ID: 16202449
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
